Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2761 AL 2775

Natural Products as Potential Anti-Alzheimer Agents

Panda SS, Jhanji N.

Curr Med Chem. 2020;27(35):5887-5917. doi: 10.2174/0929867326666190618113613.

Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer's Disease

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(32):5351-5373. doi: 10.2174/0929867326666190620095623.

Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia

Rychlik M, Mlyniec K.

Curr Neuropharmacol. 2020;18(1):2-13. doi: 10.2174/1570159X17666190704153807.

Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies

Vijayan D, Chandra R.

Curr Drug Targets. 2020;21(2):148-166. doi: 10.2174/1389450120666190806153206.

AMPK: Potential Therapeutic Target for Alzheimer's Disease

Yang L, Jiang Y, Shi L, Zhong D, Li Y, Li J, Jin R.

Curr Protein Pept Sci. 2020;21(1):66-77. doi: 10.2174/1389203720666190819142746.

Neuroprotective effects of resveratrol in Alzheimer's disease

Rao YL, Ganaraja B, Joy T, Pai MM, Ullal SD, Murlimanju BV.

Front Biosci (Elite Ed). 2020 Jan 1;12(1):139-149. doi: 10.2741/E863.

Insights from Drosophila melanogaster model of Alzheimer's disease

Tue NT, Dat TQ, Ly LL, Anh VD, Yoshida H.

Front Biosci (Landmark Ed). 2020 Jan 1;25(1):134-146. doi: 10.2741/4798.

Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(39):6658-6681. doi: 10.2174/0929867326666191011144818.

Navigating Alzheimer's Disease via Chronic Stress: The Role of Glucocorticoids

Sharma VK, Singh TG.

Curr Drug Targets. 2020;21(5):433-444. doi: 10.2174/1389450120666191017114735.

Inhibitors of Cholinesterases in Pharmacology: the Current Trends

Pohanka M.

Mini Rev Med Chem. 2020;20(15):1532-1542. doi: 10.2174/1389557519666191018170908.

An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review

Karim N, Khan H, Khan I, Guo O, Sobarzo-Sánchez E, Rastrelli L, Kamal MA.

Med Chem. 2020;16(8):1007-1021. doi: 10.2174/1573406415666191105154407.

The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis

Tolar M, Abushakra S, Sabbagh M.

Alzheimers Dement. 2020 Nov;16(11):1553-1560. doi: 10.1016/j.jalz.2019.09.075. Epub 2020 Jan 3.

Lipid lowering and Alzheimer disease risk: A mendelian randomization study

Williams DM, Finan C, Schmidt AF, Burgess S, Hingorani AD.

Ann Neurol. 2020 Jan;87(1):30-39. doi: 10.1002/ana.25642.

Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial

Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Nilforooshan R, Wilcock G, Gray R; Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group.

JAMA Neurol. 2020 Feb 1;77(2):164-174. doi: 10.1001/jamaneurol.2019.3762.

Pragmatic Trials and Repurposed Drugs for Alzheimer Disease

Schneider LS.

JAMA Neurol. 2020 Feb 1;77(2):162-163. doi: 10.1001/jamaneurol.2019.3784.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias